SIMCERE PHARMA (02096) spent 10.1667 million Hong Kong dollars to repurchase 1.49 million shares on November 18th.
Sinopharm (02096) announced that on November 18, 2024, the company invested 1016.67 million...
SIMCERE PHARMA (02096) announced that on November 18, 2024, the company repurchased 1.49 million shares at a cost of 10.167 million Hong Kong dollars. The repurchase price was between 6.71 and 6.98 Hong Kong dollars per share.
Related Articles
US Stock Market Move | Partial encryption mining concept stocks fluctuate and rise, TeraWulf (WULF.US) rises nearly 5%.
US Stock Market Move | Fujian Eastern Red (ORIS.US) Soars Over 25% and Plans to Acquire Controlling Stake in Hubei Daguan Tea Industry Group.
US Stock Market Move | New antiemetic drug Nereus approved by FDA, Vanda Pharmaceuticals Inc. (VNDA.US) surges over 32%
US Stock Market Move | Partial encryption mining concept stocks fluctuate and rise, TeraWulf (WULF.US) rises nearly 5%.
US Stock Market Move | Fujian Eastern Red (ORIS.US) Soars Over 25% and Plans to Acquire Controlling Stake in Hubei Daguan Tea Industry Group.
US Stock Market Move | New antiemetic drug Nereus approved by FDA, Vanda Pharmaceuticals Inc. (VNDA.US) surges over 32%
